skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

COSEHC global vascular risk management quality improvement program: rationale and design

Original Research

(1223) Views  (404) Full article downloads

Authors: Carlos M Ferrario, Michael A Moore, William Bestermann Jr, et al

Published Date December 2010 Volume 2010:6 Pages 1135 - 1145
DOI: http://dx.doi.org/10.2147/VHRM.S13746

Carlos M Ferrario1 Michael A Moore2 William Bestermann Jr3 Chris Colby4 Alex Exuzides4 Debra Simmons1 Sumeet Panjabi5
1Departments of General Surgery and Internal Medicine/Nephrology, 2Hypertension and Vascular Disease Research Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA; 3Vascular Medicine Center, Holston Medical Group, Kingsport, TN, USA; 4ICON Clinical Research, San Francisco, CA, USA; 5Health Economics and Outcomes Research, Daiichi Sankyo, Inc., Parsippany, NJ, USA

Background: The Consortium for Southeastern Hypertension Control (COSEHC) promotes global risk factor management in patients with metabolic syndrome. The COSEHC Global Vascular Risk Management Study (GVRM) intends to quantify these efforts on long-term patient outcomes. The objectives of this study were to present baseline demographics of patients enrolled in the GVRM, calculate a modified COSEHC risk score using 11 variables (COSEHC-11), and compare it with the original COSEHC-17 and Framingham, Prospective Cardiovascular Münster (PROCAM), and Systemic Coronary Risk Evaluation (SCORE) risk scores.
Methods: Deidentified electronic medical records of enrolled patients were used to calculate the risk scores. The ability of the COSEHC-11 score to predict the COSEHC-17 score was assessed by regression analysis. Raw risk scores were converted to probability estimates of fatal coronary heart disease (CHD) and compared with predicted risks from other algorithms.
Results: Of the 177,404 patients enrolled, 43,676 had data for all 11 variables. The COSEHC-11 score (mean ± standard deviation) of these 43,676 patients was 31.75 ± 11.66, implying a five-year fatal CHD risk of 1.4%. The COSEHC-11 score was highly predictive of the COSEHC-17 score (R2 = 0.93; P < 0.0001) and correlated well with the SCORE algorithm.
Conclusion: The COSEHC-11 risk score is statistically similar to the COSEHC-17 risk score and should be a viable tool for evaluating its ability to predict five-year cardiovascular mortality in the coming years.

Keywords: cardiovascular risk, electronic medical records, metabolic syndrome




 

Other articles by Dr Carlos Ferrario



Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
The relationship between adipokines, body composition, and bone density in men with chronic obstructive pulmonary disease
Role of olmesartan in combination therapy in blood pressure control and vascular function
Impact of a diabetic foot care education program on lower limb amputation rate
Soy use and vasomotor symptoms: Soy Estrogen Alternative follow-up study
Detection of circulating microparticles by flow cytometry: influence of centrifugation, filtration of buffer, and freezing
Hereditary diffuse gastric cancer: genetics, prophylactic total gastrectomy, and follow up
Bronchodilator efficacy and safety of indacaterol 150 µg once daily in patients with COPD: an analysis of pooled data
Skeletal myotube formation enhanced by electrospun polyurethane carbon nanotube scaffolds
The effect of reminder systems on patients' adherence to treatment
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University